Pharmacist Impact on Documentation of QOPI Patient Education Standards for Ambulatory Parenteral Chemotherapy C. Terrell; S. Walton; M. Curry; J. LaFollette; L. Bernal-Mizrachi Grady Health System - Atlanta, GA
Background/Purpose: In 2002, the American Society of Clinical Oncology established the Quality Oncology Practice Initiative (QOPI), a standards-based quality assessment program. Certification standards are separated into domains which address treatment planning, consent and education. This study evaluated the impact of pharmacist-led chemotherapy education on complete documentation of QOPI patient education standards for patients who received treatment in an ambulatory infusion center.
Methodology: The study evaluated documentation of Domain 2 QOPI patient education standards in the electronic medical record (EMR) during two time periods. Phase I consisted of a baseline retrospective review of patient education documentation in the EMR for patients starting a new chemotherapy regimen (n=50) from January 2017 to September 2017. A separate quality initiative, development of a comprehensive provider note template, was implemented in June 2017 to increase documentation quality. Phase I data collection included consecutive patients both pre- (n=25) and post-implementation (n=25) of the provider note template. Phase II (November 2017-March 2018) consisted of development of regimen-specific education note templates by the PGY2 oncology resident, pharmacist-led patient education (n=50), and concurrent chart evaluation of QOPI-required EMR documentation.
Results: One hundred charts were evaluated between phases I (n=50) and II (n=50). Complete documentation of QOPI patient education standards has increased after creation of regimen-specific templates (100% vs 0%). In phase II, all patients have individual standards documented (18/18; 100%) compared to, in phase I, a median of 9/18 (50%) prior to- and 10/18 (55.6%) post- provider note template.
Conclusions: Data suggest that chemotherapy education documentation utilizing regimen-specific templates created by an oncology clinical pharmacist increases documentation of QOPI standards in an ambulatory setting.
Presentation Objective: Evaluate the impact of pharmacist-led chemotherapy education documentation on completeness of QOPI education standards.
Self-Assessment: Which QOPI patient education standard demonstrated the most improvement as a result of pharmacist-developed templates?
